Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Possible origin of murine AIDS-inducing sequence.
Kubo Y, Higo K, Kobayashi H, Ono T, Iwama Y, Yanagawa S, Adachi A, Ishimoto A. Kubo Y, et al. Among authors: ono t. Leukemia. 1997 Apr;11 Suppl 3:163-6. Leukemia. 1997. PMID: 9209331
Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system.
Zhang F, Ya LT, Iwatani Y, Higo K, Suzuki Y, Tanaka M, Nakahara T, Ono T, Sakai H, Kuribayashi K, Ishimoto A. Zhang F, et al. Among authors: ono t. J Virol. 2000 Jul;74(13):6193-7. doi: 10.1128/jvi.74.13.6193-6197.2000. J Virol. 2000. PMID: 10846105 Free PMC article.
However, the resistance caused by Fv-4 is recessive in nude mice, which suggests that immunological effects play important roles in this resistance in vivo (K. Higo, Y. Kubo, Y. Iwatani, T. Ono, M. Maeda, H. Hiai, T. Masuda, K. Kuribayashi, F. Zhang, T
However, the resistance caused by Fv-4 is recessive in nude mice, which suggests that immunological effects play important roles in this res …
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection.
Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S, Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J, Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H, Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H, Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T, Endo H, Tominaga T. Kanamori M, et al. Among authors: ono t. Int J Clin Oncol. 2024 Nov 11. doi: 10.1007/s10147-024-02650-9. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39527165
4,589 results